Bristol-Myers Squibb (BMY) Q2 Earnings: What To Expect
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results this Thursday morning. Here’s what you need to…
Bristol Myers, Bain Capital form new company to develop immunology drugs
(Reuters) -Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on…
BioNTech Stock Jumps on Bristol Myers Squibb Cancer Drug Collaboration
Sean Gallup / Getty Images Bristol Myers Squibb will pay $1.5 billion to BioNTech up front, with up…
BioNTech Gains 20% On $11.1 Billion Bristol Deal
BioNTech (NASDAQ:BNTX) surged 20% after Bristol Myers Squibb (NYSE:BMY) agreed to license its bispecific antibody BNT327targeting PD-L1 and…
Trump’s steel tariffs, Bristol Myers-BioNTech, sports bet tax
00:00 Speaker A It’s time for Yahoo Finance’s Market Minute. Stocks mixed to kick off June as tensions…
Netflix’s new high, Bristol Myers outlook, Texas Instruments pops
00:00 Speaker A It’s time for Yahoo! Finance’s Market Minute. Tech stocks leading the rally as investors look…
Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect
Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing…
Bristol Myers’ Cobenfy Falls Short On Primary Endpoint In Phase 3 Schizophrenia Trial, Stock Slides
Bristol Myers Squibb & Co (NYSE:BMY) on Tuesday released topline results from the Phase 3 ARISE trial evaluating the…
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term
It doesn’t matter your age or experience: taking full advantage of the stock market and investing with confidence…
Patent Cliff Looms Large for Bristol-Myers Squibb Stock (BMY)
Bristol-Myers Squibb (BMY) stock is down 11% year-to-date as the company navigates several looming patent cliffs. After a…